These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 36702610)

  • 1. Improving representativeness in trials: a call to action from the Global Cardiovascular Clinical Trialists Forum.
    Filbey L; Zhu JW; D'Angelo F; Thabane L; Khan MS; Lewis E; Patel MR; Powell-Wiley T; Miranda JJ; Zuhlke L; Butler J; Zannad F; Van Spall HGC
    Eur Heart J; 2023 Mar; 44(11):921-930. PubMed ID: 36702610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The causes and effects of socio-demographic exclusions from clinical trials.
    Bartlett C; Doyal L; Ebrahim S; Davey P; Bachmann M; Egger M; Dieppe P
    Health Technol Assess; 2005 Oct; 9(38):iii-iv, ix-x, 1-152. PubMed ID: 16181564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mobile phone-based interventions for improving adherence to medication prescribed for the primary prevention of cardiovascular disease in adults.
    Palmer MJ; Barnard S; Perel P; Free C
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD012675. PubMed ID: 29932455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple risk factor interventions for primary prevention of cardiovascular disease in low- and middle-income countries.
    Uthman OA; Hartley L; Rees K; Taylor F; Ebrahim S; Clarke A
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD011163. PubMed ID: 26272648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Representativeness of a Heart Failure Trial by Race and Sex: Results From ASCEND-HF and GWTG-HF.
    Greene SJ; DeVore AD; Sheng S; Fonarow GC; Butler J; Califf RM; Hernandez AF; Matsouaka RA; Samman Tahhan A; Thomas KL; Vaduganathan M; Yancy CW; Peterson ED; O'Connor CM; Mentz RJ
    JACC Heart Fail; 2019 Nov; 7(11):980-992. PubMed ID: 31606362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving Enrollment of Underrepresented Racial and Ethnic Populations in Heart Failure Trials: A Call to Action From the Heart Failure Collaboratory.
    DeFilippis EM; Echols M; Adamson PB; Batchelor WB; Cooper LB; Cooper LS; Desvigne-Nickens P; George RT; Ibrahim NE; Jessup M; Kitzman DW; Leifer ES; Mendoza M; Piña IL; Psotka M; Senatore FF; Stein KM; Teerlink JR; Yancy CW; Lindenfeld J; Fiuzat M; O'Connor CM; Vardeny O; Vaduganathan M
    JAMA Cardiol; 2022 May; 7(5):540-548. PubMed ID: 35319725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex Disparities in Cardiovascular Device Evaluations: Strategies for Recruitment and Retention of Female Patients in Clinical Device Trials.
    Ghare MI; Chandrasekhar J; Mehran R; Ng V; Grines C; Lansky A
    JACC Cardiovasc Interv; 2019 Feb; 12(3):301-308. PubMed ID: 30732736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the representativeness and generalizability of Japanese clinical trials for localized rectal/colon cancer: Comparing participants in the Japan Clinical Oncology Group study with patients in Japanese registries.
    Miyamoto K; Wakabayashi M; Mizusawa J; Nakamura K; Katayama H; Higashi T; Inomata M; Kitano S; Fujita S; Kanemitsu Y; Fukuda H
    Eur J Surg Oncol; 2020 Sep; 46(9):1642-1648. PubMed ID: 32340817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of cardiovascular disease prevalence on women's enrollment in landmark randomized cardiovascular trials: a systematic review.
    Tsang W; Alter DA; Wijeysundera HC; Zhang T; Ko DT
    J Gen Intern Med; 2012 Jan; 27(1):93-8. PubMed ID: 21713543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recruitment of Black Adults into Cardiovascular Disease Trials.
    Prasanna A; Miller HN; Wu Y; Peeler A; Ogungbe O; Plante TB; Juraschek SP
    J Am Heart Assoc; 2021 Sep; 10(17):e021108. PubMed ID: 34431310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recruiting equal numbers of indigenous and non-indigenous participants to a 'polypill' randomized trial.
    Selak V; Crengle S; Elley CR; Wadham A; Harwood M; Rafter N; Bullen C; Pillai A; Arroll B; Rodgers A
    Int J Equity Health; 2013 Jun; 12():44. PubMed ID: 23800177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Racial, Ethnic, and Geographic Location Diversity of Participants Enrolled in Clinic-Based vs 2 Remote COVID-19 Clinical Trials.
    Stewart J; Krows ML; Schaafsma TT; Heller KB; Brown ER; Boonyaratanakornkit J; Brown CE; Leingang H; Liou C; Bershteyn A; Schwartz MD; Agrawal V; Friedman-Klabanoff D; Eustace S; Stankiewicz Karita HC; Paasche-Orlow MK; Kissinger P; Hosek SG; Chu HY; Celum C; Baeten JM; Wald A; Johnston C; Barnabas RV
    JAMA Netw Open; 2022 Feb; 5(2):e2148325. PubMed ID: 35157053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mobile phone-based interventions for improving adherence to medication prescribed for the primary prevention of cardiovascular disease in adults.
    Palmer MJ; Machiyama K; Woodd S; Gubijev A; Barnard S; Russell S; Perel P; Free C
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD012675. PubMed ID: 33769555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection by inclusion: Increasing enrollment of women in cardiovascular trials.
    Filbey L; Khan MS; Van Spall HGC
    Am Heart J Plus; 2022 Jan; 13():100091. PubMed ID: 38560056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recruitment to randomised trials: strategies for trial enrollment and participation study. The STEPS study.
    Campbell MK; Snowdon C; Francis D; Elbourne D; McDonald AM; Knight R; Entwistle V; Garcia J; Roberts I; Grant A; Grant A;
    Health Technol Assess; 2007 Nov; 11(48):iii, ix-105. PubMed ID: 17999843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LEADER Trial Eligibility and Preventable Cardiovascular Events in US Adults with Diabetes: the National Health and Nutrition Examination Surveys 2007-2016.
    Fan W; Tong C; Wong ND
    Cardiovasc Drugs Ther; 2020 Dec; 34(6):737-743. PubMed ID: 32621045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GIST 2.0: A scalable multi-trait metric for quantifying population representativeness of individual clinical studies.
    Sen A; Chakrabarti S; Goldstein A; Wang S; Ryan PB; Weng C
    J Biomed Inform; 2016 Oct; 63():325-336. PubMed ID: 27600407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Underserved groups remain underserved as eligibility criteria routinely exclude them from breast cancer trials.
    Moloney C; Shiely F
    J Clin Epidemiol; 2022 Jul; 147():132-141. PubMed ID: 35341945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.